Association of serum total testosterone concentration with skeletal muscle mass in men under hemodialysis. 2014

Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
Department of Clinical Nutrition, School of Food and Nutritional Sciences, University of Shizuoka, 52-1 Yada, Shizuoka, 422-8526, Japan.

OBJECTIVE Although skeletal muscle wasting can occur in chronic kidney diseases, its relationship with the serum testosterone concentration remains uncertain. This study investigates the relationship between serum testosterone and skeletal muscle mass in men under hemodialysis (HD). METHODS Sixty men aged between 41 and 89 years undergoing HD for 15.0 ± 8.1 years were enrolled for this study. The muscle areas of the thigh (TMA) and abdomen (AMA) were measured by computed tomography (CT), and the association between these muscle areas and serum total testosterone was examined with adjustment of age and other nutritional variables. RESULTS The mean serum total testosterone in our HD patients (6.33 ± 2.90 ng/mL) was not lower than that of the Japanese general population, but showed a positive correlation with TMA (r = 0.39, p < 0.05), AMA (r = 0.52, p < 0.001), serum creatinine (r = 0.33, p < 0.05), and the creatinine generation rate (r = 0.26, p < 0.05). Serum total testosterone was inversely correlated with age (r = -0.32, p < 0.05), CRP (r = -0.31, p < 0.05), and IL-6 (r = -0.24, p < 0.05). A multiple-regression analysis showed both serum total testosterone and age to be an independent determinant of the muscle mass in these patients. CONCLUSIONS This study identified testosterone as a determinant of muscle mass in HD men.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000009 Abdominal Muscles Muscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS; ABDOMINAL OBLIQUE MUSCLES, transversus abdominis, pyramidalis muscles and quadratus abdominis. Cremaster Muscle,Pyramidalis Muscle,Quadratus Abdominis,Transverse Abdominal,Transversus Abdominis,Abdominal Muscle,Abdominal, Transverse,Abdominals, Transverse,Abdomini, Quadratus,Abdominis, Quadratus,Cremaster Muscles,Muscle, Abdominal,Muscle, Cremaster,Muscle, Pyramidalis,Muscles, Abdominal,Muscles, Cremaster,Muscles, Pyramidalis,Pyramidalis Muscles,Quadratus Abdomini,Transverse Abdominals
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
January 1998, Archives of andrology,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
January 2015, Pakistan journal of medical sciences,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
February 2024, Asian spine journal,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
December 2022, Journal of the Formosan Medical Association = Taiwan yi zhi,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
June 2003, Diabetes care,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
June 2018, Journal of clinical laboratory analysis,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
July 2016, Atherosclerosis,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
September 2019, Circulation reports,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
June 2001, Neuro endocrinology letters,
Gloria Kojo, and Takuya Yoshida, and Sakae Ohkawa, and Mari Odamaki, and Akihiko Kato, and Takako Takita, and Yukitaka Maruyama, and Hiromichi Kumagai
September 2007, Metabolism: clinical and experimental,
Copied contents to your clipboard!